Literature DB >> 16924240

hHR23B is required for genotoxic-specific activation of p53 and apoptosis.

M Kaur1, M Pop, D Shi, C Brignone, S R Grossman.   

Abstract

Rad23 proteins function in both DNA repair and protein stability regulation. As ubiquitinated forms of p53 are stabilized after DNA damage in concert with p53 functional activation, and human Rad23 proteins (hHR23A and B) regulate p53 stability in unstressed cells, the role of hHR23B in post-genotoxin regulation of p53 was investigated. Depletion of hHR23B by specific short interfering RNA before genotoxic exposure attenuated p53, p21 and bax induction, abrogated the accumulation of ubiquitinated p53 and suppressed apoptosis. Expression of ubiquitin derivatives with all lysines mutated except K48 or K63 demonstrated that K48-linked p53-ubiquitin conjugates were specifically induced after DNA damage. hHR23B, along with native and ubiquitinated p53, accumulated in chromatin after genotoxic exposure, and the accumulation of ubiquitinated p53 in chromatin was prevented by hHR23B depletion. Chromatin immunoprecipitation analysis demonstrated that hHR23B and p53 both localized to the p21 promoter shortly after DNA damage. hHR23B thus plays a critical role in the activation and function of p53 after specific genotoxic exposures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924240      PMCID: PMC1804095          DOI: 10.1038/sj.onc.1209865

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II.

Authors:  Anna Kruczynski; Jean-Marc Barret; Benoît Van Hille; Nathalie Chansard; Jackie Astruc; Yoann Menon; Carole Duchier; Laurent Créancier; Bridget T Hill
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

3.  Developmental defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B.

Authors:  Jessica M Y Ng; Harry Vrieling; Kaoru Sugasawa; Marja P Ooms; J Anton Grootegoed; Jan T M Vreeburg; Pim Visser; Rudolph B Beems; Theo G M F Gorgels; Fumio Hanaoka; Jan H J Hoeijmakers; Gijsbertus T J van der Horst
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  The fate of p21CDKN1A in cells surviving UV-irradiation.

Authors:  Toshiki Itoh; Stuart Linn
Journal:  DNA Repair (Amst)       Date:  2005-09-22

5.  MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

Authors:  Patima Sdek; Haoqiang Ying; Donny L F Chang; Wei Qiu; Hongwu Zheng; Robert Touitou; Martin J Allday; Zhi-Xiong Jim Xiao
Journal:  Mol Cell       Date:  2005-12-09       Impact factor: 17.970

6.  Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.

Authors:  A I Robles; X W Wang; C C Harris
Journal:  Oncogene       Date:  1999-08-19       Impact factor: 9.867

7.  Rad23 ubiquitin-associated domains (UBA) inhibit 26 S proteasome-catalyzed proteolysis by sequestering lysine 48-linked polyubiquitin chains.

Authors:  Shahri Raasi; Cecile M Pickart
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

8.  HHR23A, a human homolog of Saccharomyces cerevisiae Rad23, regulates xeroderma pigmentosum C protein and is required for nucleotide excision repair.

Authors:  Hui-Chuan Hsieh; Yi-Hsuan Hsieh; Yu-Hsin Huang; Fan-Ching Shen; Han-Ni Tsai; Jui-He Tsai; Yu-Ting Lai; Yu-Ting Wang; Woei-Jer Chuang; Wenya Huang
Journal:  Biochem Biophys Res Commun       Date:  2005-09-16       Impact factor: 3.575

9.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

Review 10.  To die or not to die: how does p53 decide?

Authors:  Elizabeth A Slee; Daniel J O'Connor; Xin Lu
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

View more
  5 in total

Review 1.  Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance.

Authors:  Lauren S Waters; Brenda K Minesinger; Mary Ellen Wiltrout; Sanjay D'Souza; Rachel V Woodruff; Graham C Walker
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

2.  CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.

Authors:  Dingding Shi; Marius S Pop; Roman Kulikov; Ian M Love; Andrew L Kung; Andrew Kung; Steven R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

3.  Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith-Lemli-Opitz Syndrome.

Authors:  Bruce A Pfeffer; Libin Xu; Steven J Fliesler
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 6.208

4.  The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.

Authors:  A Sparks; S Dayal; J Das; P Robertson; S Menendez; M K Saville
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

5.  DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination.

Authors:  Oluwatoyin E Akande; Priyadarshan K Damle; Marius Pop; Nicholas E Sherman; Barbara B Szomju; Larisa V Litovchick; Steven R Grossman
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.